Loading...
Loading...
Bacterin International
Holdings, Inc.
, a leader in the development of bone graft
material and bioactive coatings for medical applications, today announced
three senior additions to its Field Sales Organization.
Amy Radtke has joined us as a Director of IDN/ National Accounts. Amy has 14
years of medical sales and national management experience with a track record
of success at Lumenis, Burwood Group, Inc., and Dräger Medical, Inc.
Troy Knief has also joined us as a Director of IDN/National Accounts. In his
13 years of medical sales, sales management and national account management
experience he brings a track record of success at Baxter Healthcare/ApaTech
Division, Anulex Technologies, Synthes Spine, MedPointe Pharmaceuticals and
Forest Pharmaceuticals.
Kevin M. O'Dare has joined us as Regional Vice President in our Pennsylvania
and New England region. With over 14 years in the medical device field, he
brings a track record of success at Olympus Biotech (formerly Stryker
Biotech), Ethicon-EndoSurgery and Osteotech, Inc.
Robert Di Silvio, President explained, "We see an excellent opportunity for
growth in Integrated Delivery Networks (IDNs), and the Federal Government,
where the organizations can define and dictate product usage and can
effectively influence the end-user surgeon. For this reason, one leg of
Bacterin's strategy is to add experienced selling resources with relationships
in GPO/IDN and Federal Government immediately."
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in